These data suggest that OPN may have a key role in modulating the MET process in medullary thyroid cancer, instead of inducing a mesenchymal-like phenotype, of which we continue to explore the underlying molecular mechanisms that are yet to be elucidated. This evidence concerns the gene SPP1 and medullary thyroid gland carcinoma.